US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Dropbox Inc (1DBX) 銘柄情報

Dropbox Inc (1DBX)

0.00

0.00

(0.00%)

終了 7月12日 12:30AM

Dropbox Inc (1DBX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

平均取引量 (3 か月)

3,938,000 €

財務取引量

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

企業価値

9.383B

前日終値

-

始値

-

時刻

最終取引時間

VWAP

-

歳入

2.53B

純利益

472.6M

発行済株式数

233,300,649

浮動株比率 (%)

61.71%

機関投資家保有比率 (%)

81.59%

配当利回り

PER

15.67

株価売上高倍率 (PSR)

2.64

1 株当たり利益 (EPS)

1.82

ベータ

0.66

Dropbox, Inc. provides a content collaboration platform in the United States and internationally. The company’s platform enables individuals, families, teams, and organizations to collaborate for free through its website or app, or through a paid subscription plan for premium features. Its platform ... Dropbox, Inc. provides a content collaboration platform in the United States and internationally. The company’s platform enables individuals, families, teams, and organizations to collaborate for free through its website or app, or through a paid subscription plan for premium features. Its platform consists of various elements, such as unified home for content, global sharing network, and product experiences and integrations. The company serves customers in the professional services, technology, media, education, industrial, consumer and retail, and financial services industries. The company was formerly known as Evenflow, Inc. and changed its name to Dropbox, Inc. in October 2009. Dropbox, Inc. was incorporated in 2007 and is headquartered in San Francisco, California. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.dropbox.com

本社

San Francisco, United States

設立

2026

Dropbox Inc is listed in the sector of the イタリア証券取引所 with ticker 1DBX. The last closing price for Dropbox was -. Over the last year, Dropbox shares have traded in a share price range of 0.00 € to 0.00 €.

Dropbox currently has 233,300,649 shares in issue. Dropbox has a price to earnings ratio (PE ratio) of 15.67.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

1DBX - Frequently Asked Questions (FAQ)

What is the current Dropbox Inc share price?

The current share price of Dropbox Inc is 0.00 €

How many Dropbox Inc shares are in issue?

Dropbox Inc has 233,300,649 shares in issue

What is the 1 year trading range for Dropbox Inc share price?

Dropbox Inc has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Dropbox Inc?

The price to earnings ratio of Dropbox Inc is 15.67

What is the cash to sales ratio of Dropbox Inc?

The cash to sales ratio of Dropbox Inc is 2.64

What is the registered address of Dropbox Inc?

The registered address for Dropbox Inc is 1800 Owens Street, San Francisco, California, 94158

What is the Dropbox Inc website address?

The website address for Dropbox Inc is www.dropbox.com

WebSlinger

WebSlinger 4分前

Another day….

Another week….

Another word-salad PR….

Another big, fat, juicy, KBLB nothingburger….

with a side order of lies….

https://i.imgflip.com/3bm6mk.jpg

12yearplan

12yearplan 6分前

Whah!, so good Jack!.. don't know how I missed that one and
Ties right back to previous horse conversations and why
Staying with the horses is going to pay off for all concerned;

Another blinger with the slick trigger finger for Her Majesty
Another one, with the g

newflow

newflow 6分前

As per 7th amended plan or reorganization there was no 75% to Class 19 and 25% to Class 22 thru the end even distributions from PAC?.
Gemini's Response:
The Seventh Amended Plan of Reorganization does not establish a fixed "75/25" split for distributions. The idea of a 75/25 split is a

Denisk

well RMB don't worry so much about it, besides Kiwi is having cffee and England just beat Norway to go in the FIFA semi final.😉

Truthsocial

Truthsocial 14分前

RDGL SUPERIOR Vivos Inc's RadioGel® competes with established Y-90 therapies like TheraSphere (glass microspheres) and SIR-Spheres (resin microspheres) by targeting a fundamentally different clinical niche: direct intratumoral injection versus intra-arterial infusion.

RDGL SUPER

trunkmonk

trunkmonk 15分前

looks like Clarity, if passed by senate in July, can be law by Aug 7th.
Looking at risk, if it does not pass senate, sometime this month will be vote, then what, will the drop be short term, will other countries buffer the loss of progress in US? lets hope and pray they pass it, or US will b

lakers17

lakers17 16分前

CZ (Binance Founder) just mapped the path to $1 MILLION Bitcoin: "The last cycle was only 2X.
Next cycle 5X gets us to ~$600K. Then the 2033 cycle only needs another 2X to hit $1M."

Demand? Still

NotTheRealBeeny

NotTheRealBeeny 16分前

I think we're talking about two different things.

You're explaining how pleadings are organized. I don't disagree with any of that.

My point has nothing to do with causes of action, numbered paragraphs, summaries, or conclusions.

My point is the language

BIOChecker4

BIOChecker4 18分前

Most damning analysis I have read so far.

This was a disaster-in-the-making from the very start.

fdicr

Too much news of nothing going on for years. THERE WILL NOT BE ANOTHER BANKING CRISIS. Why ? because feds learned from the financial crisis of 2008 that they can print trillions if they need to rescue big banks. Crisis will happen to little local banks but they all will be absorbed by FDIC. SO, DO N

Shrinky Dynk

Shrinky Dynk 21分前

https://www.instagram.com/p/DaodEwimQuz/?utm_source=ig_web_copy_link&igsh=NTc4MTIwNjQ2YQ==

Lifetime

Lifetime 25分前

FFS please, please learn what revenue, gross profit, net profit and COGS mean. GREATNESS from learning basic finance terms

BlueSky195

BlueSky195 29分前

You don’t have a clue what is really going on, quit spewing your wild guess's. Watcher too, just stop with your rambling speculations.

Truthsocial

Truthsocial 30分前

Current Status and Next Steps
Vivos Inc. received FDA Investigational Device Exemption (IDE) approval for its RadioGel study on July 6, 2026. This clearance allows the company to initiate its first-in-human feasibility study at Mayo Clinic in Jacksonville, Florida. However, the study cannot

12yearplan

12yearplan 31分前

'NAH!" ??????????????????????????

was the exclamation point really necessary????????????????? !

If I understand all that previous interest discussion even half correctly I think you may have that characteristic wise and witty trading strategy still in tow and that you m

condor1

condor1 31分前

Biased Beeny, while you often make good arguing points, as to legal pleadings, I know a lot, while conversely, you have demonstrated that you know very little.
Applebaum isforming his pleading like most, if not all attorneys. There is a second cause of action after the first cause of act

havnagoodtime

havnagoodtime 33分前

It is for the benefit of whoever follows along.

My hand is raised. Thank you for your time and effort.

reachjo

reachjo 33分前

My bet is by early September, maybe sooner.

Doc logic

Doc logic 37分前

manibiotech,

Maybe we should all just focus on the manufacturing updates because until then, and getting off of OTC with partnership news, the question will be about manufacturing profitably and ability to ramp up even after an approval without that news. Approval is great but partne

Jlo32

Hey Tenkay check out Greg on LinkedIn

mrsdoubtfire

mrsdoubtfire 39分前

well as far as i know vakster stepped down

ListenToTheTrees

ListenToTheTrees 42分前

You’re entitled to your opinion, but labeling anyone who disagrees with you an “apologist” doesn’t strengthen your argument.

You say your facts haven’t been refuted, but that’s not really the issue. The debate has always been about the conclusions you draw from those facts.

goodietime

goodietime 46分前

BMO MSCI USA High Qualit...

RSD vs US Dollar

Raiffeisen Bank

Global X ETF ICAV

Cosmos Insuranc

Nikon Slm Solutions

Polaris Media ASA

Genetic Technologies (EM)

MBX Biosciences

Oportun Financial

Blackrock luxembourg

Multi Call Zero Cpn Nts ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。